CTRI/2020/02/023105
Not yet recruiting
Phase 2
AN OPEN LABEL CLINICAL STUDY TO EVALUATE THE EFFECTIVENESS OF PADAPICHU BANDHANA WITH NIRGUNDI TAILA IN VATAKANTAKA
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: M678- Other specified disorders of synovium and tendon
- Sponsor
- Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Subjects fulfilling the diagnostic criteria.
- •2\.Subjects with symptoms of Plantar Fascitis, Calcaneal spur.
- •3\.Subjects with either gender between age group 20\-60years.
- •4\.Subjects who are willing to participate and sign the informed consent form.
Exclusion Criteria
- •1\.Subjects with fracture and dislocation of ankle joint, foot and sprain.
- •2\.Subjects with impaired circulation to lower extremities.
- •3\.Subjects with systemic disorders.
- •4\.Subjects with foot infection.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Study to Determine the Effect of Trucrose in Patients with Type II Diabetes MellitusHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2020/07/026346Trulit Herbals
Not yet recruiting
Phase 2
An Clinical Study of Evecare Forte Liquid in PCOS (Polycystic Ovarian Syndrome)CTRI/2017/12/011004The Himalaya Drug Company
Completed
Phase 4
A clinical study to evaluate the efficacy and safety of URAL tabletCTRI/2023/04/051931Vasu Research Centre
Not yet recruiting
Phase 2
A Study to Evaluate The Effect of Draksha (Vitis Vinifera Lin) Panak in Dyslipidaemia.Health Condition 1: E784- Other hyperlipidemiaCTRI/2021/07/034572Sane Guruji Arogya Kendra
Active, not recruiting
Not Applicable
Clinical Efficacy of Sofosbuvir with Ribavirin as Pre-Emptive Administration in Transplant-Recipients with Hepatitis C Virus (HCV) active infectioHCV active infection at the time of OLTTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2014-002317-32-ITAzienda Ospedaliera Papa Giovanni XXIII50